- American Society for Transplantation and Cellular Therapy
Tiffany Simms-Waldrip, M.D.
- Pediatrics - Hematology-Oncology
- Pediatric hematology-oncology
- Hematopoietic stem cell transplant
Biography
Tiffany Simms-Waldrip, M.D., is an Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. She specializes in pediatric hematology-oncology and focuses her research on hematopoietic stem cell transplant, transplant for bone marrow failure syndromes, and graft-versus-host disease.
Dr. Simms-Waldrip earned her medical degree at Texas Tech University Health Sciences Center. She performed her residency in pediatrics at UCLA Medical Center, where she also completed a fellowship in pediatric hematology-oncology.
Certified by the American Board of Pediatrics in pediatric hematology-oncology, she joined the UT Southwestern faculty in 2010.
Dr. Simms-Waldrip is the Clinical Director of Pediatric Hematopoietic Stem Cell Transplant (HSCT) at UT Southwestern and Children’s Medical Center Dallas. She also serves as the HSCT Education Coordinator and HSCT Bone Marrow Failure Physician at both institutions.
She is a member of the American Society for Transplantation and Cellular Therapy and serves on numerous committees, including as Chair of the Tissue and Transfusion Utilization Committee at Children’s. In addition, she is a Pediatrics Residency Program mentor at UTSW.
She has published numerous academic articles.
Education & Training
- Medical School - Texas Tech University Health Sciences Center (2000-2004)
- Fellowship - University of California, Los Angeles (2007-2010), Pediatric Hematology/oncology
- Residency - University of California, Los Angeles (2004-2007), Pediatrics
Professional Associations & Affiliations
Honors & Awards
- Clinical Research Training Scholar 2011, American Society of Blood and Marrow Transplantation
- NIH T32 Developmental Hematology Training Grant 2008-2011, National Institutes of Health
- AAP Resident Research Grant 2006, American Academy of Pediatrics
- Magna Cum Laude 2000, Texas Christian University
Books & Publications
-
Publications
-
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes
Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman RE, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel PA, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds Jr. RR, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X Transplantation and Cellular Therapy 2022 Feb 28 113.e1-113.e8 -
Invasive fungal infections while on voriconazole, liposomal amphotericin B, or micafungin for antifungal prophylaxis in pediatric stem cell transplant patients
Bui A, Nguyen V, Hsu C, Hyde B, Simms-Waldrip T Journal of Pediatric Pharmacology and Therapeutics 2019 May 24 220-226 -
Food for Gut: Microbiota Fuels Immune Reconstitution after BMT
Simms-Waldrip TR, Koh AY Cell Host and Microbe 2018 Apr 23 423-424 -
Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients
Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh A Biology of Blood and Marrow Transplantation 2017 May 23 820-829 -
Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization
Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh A Nature medicine 2015 Jul 21 808-814 -
Invasive fungal infections in pediatric hematopoietic stem cell transplant patients
Simms-Waldrip T, Rosen G, Nielsen-Saines K, Ikeda A, Brown B, Moore T Infectious Diseases 2015 47 218-224 -
Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT
Simms-Waldrip T, Ikeda A, Goldfinger D, Moore T, Yuan S Bone Marrow Transplantation 2010 Jan 45 201-202 -
Corrigendum to "The aggresome pathway as a target for therapy in hematologic malignancies" [Mol. Genet. Metab. 94 (2008) 283-286] (DOI:10.1016/j.ymgme.2008.03.012)
Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM Molecular Genetics and Metabolism 2009 Jun 97 164 -
The aggresome pathway as a target for therapy in hematologic malignancies
Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM Molecular Genetics and Metabolism 2008 Jul 94 283-286 -
Role of the aggresome pathway in cancer: Targeting histone deacetylase 6-dependent protein degradation
Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM Cancer research 2008 Apr 68 2557-2560 -
FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia
Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM STEM CELLS 2006 May 24 1174-1184
-
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes
Research
- Hematopoietic stem cell transplant
- Transplant for bone marrow failure syndromes
- Graft-versus-host disease
Clinical Focus
- Pediatric hematology-oncology
- Hematopoietic stem cell transplant
- Transplant for bone marrow failure syndromes
- Graft-Versus-Host Disease
Children's Medical Center of Dallas
1935 Medical District DriveDallas, Texas 75235 214-730-5437 Directions to Children's Medical Center of Dallas at Children's Medical Center of Dallas, Dallas